To validate that the beneficial effects of ChemR23 signaling were independent of hyperlipidemia and atherosclerosis, we finally used a normolipidemic model by direct aortic valve wire injury in ChemR23+/+ and ChemR23−/− mice. The gene discussed is CMKLR1; the disease is atherosclerosis.